vs
MGIC INVESTMENT CORP（MTG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
MGIC INVESTMENT CORP的季度营收约是Ultragenyx Pharmaceutical Inc.的1.4倍（$297.1M vs $207.3M），MGIC INVESTMENT CORP净利率更高（55.6% vs -62.0%，领先117.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -3.0%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -1.4%）
MGIC投资集团（纽交所代码：MTG）是美国专业的私人抵押贷款保险服务商，总部位于威斯康星州密尔沃基市，主要为美国本土住房抵押贷款业务提供保险解决方案，帮助贷款机构管控信用风险，助力普通消费者顺利获得购房贷款支持。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MTG vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $297.1M | $207.3M |
| 净利润 | $165.3M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 55.6% | -62.0% |
| 营收同比 | -3.0% | 25.9% |
| 净利润同比 | -10.9% | 3.5% |
| 每股收益（稀释后） | $0.76 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | $297.1M | — | ||
| Q4 25 | $298.7M | $207.3M | ||
| Q3 25 | $304.5M | $159.9M | ||
| Q2 25 | $304.2M | $166.5M | ||
| Q1 25 | $306.2M | $139.3M | ||
| Q4 24 | $301.4M | $164.6M | ||
| Q3 24 | $306.6M | $139.5M | ||
| Q2 24 | $305.3M | $147.0M |
| Q1 26 | $165.3M | — | ||
| Q4 25 | $169.3M | $-128.6M | ||
| Q3 25 | $191.1M | $-180.4M | ||
| Q2 25 | $192.5M | $-115.0M | ||
| Q1 25 | $185.5M | $-151.1M | ||
| Q4 24 | $184.7M | $-133.2M | ||
| Q3 24 | $200.0M | $-133.5M | ||
| Q2 24 | $204.2M | $-131.6M |
| Q1 26 | — | — | ||
| Q4 25 | 71.2% | -54.7% | ||
| Q3 25 | 77.2% | -106.9% | ||
| Q2 25 | 80.9% | -64.8% | ||
| Q1 25 | 76.6% | -102.6% | ||
| Q4 24 | 77.9% | -74.3% | ||
| Q3 24 | 82.9% | -94.6% | ||
| Q2 24 | 85.1% | -79.1% |
| Q1 26 | 55.6% | — | ||
| Q4 25 | 56.7% | -62.0% | ||
| Q3 25 | 62.8% | -112.8% | ||
| Q2 25 | 63.3% | -69.0% | ||
| Q1 25 | 60.6% | -108.5% | ||
| Q4 24 | 61.3% | -80.9% | ||
| Q3 24 | 65.2% | -95.7% | ||
| Q2 24 | 66.9% | -89.5% |
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.75 | $-1.28 | ||
| Q3 25 | $0.83 | $-1.81 | ||
| Q2 25 | $0.81 | $-1.17 | ||
| Q1 25 | $0.75 | $-1.57 | ||
| Q4 24 | $0.71 | $-1.34 | ||
| Q3 24 | $0.77 | $-1.40 | ||
| Q2 24 | $0.77 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $235.1M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.0B | $-80.0M |
| 总资产 | $6.4B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | $235.1M | — | ||
| Q4 25 | $369.0M | $421.0M | ||
| Q3 25 | $266.9M | $202.5M | ||
| Q2 25 | $294.9M | $176.3M | ||
| Q1 25 | $207.0M | $127.1M | ||
| Q4 24 | $229.5M | $174.0M | ||
| Q3 24 | $288.6M | $150.6M | ||
| Q2 24 | $281.8M | $480.7M |
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.1B | $-80.0M | ||
| Q3 25 | $5.2B | $9.2M | ||
| Q2 25 | $5.2B | $151.3M | ||
| Q1 25 | $5.1B | $144.2M | ||
| Q4 24 | $5.2B | $255.0M | ||
| Q3 24 | $5.3B | $346.8M | ||
| Q2 24 | $5.1B | $432.4M |
| Q1 26 | $6.4B | — | ||
| Q4 25 | $6.6B | $1.5B | ||
| Q3 25 | $6.6B | $1.2B | ||
| Q2 25 | $6.5B | $1.3B | ||
| Q1 25 | $6.5B | $1.3B | ||
| Q4 24 | $6.5B | $1.5B | ||
| Q3 24 | $6.7B | $1.5B | ||
| Q2 24 | $6.5B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $230.8M | $-99.8M | ||
| Q3 25 | $215.4M | $-91.4M | ||
| Q2 25 | $183.0M | $-108.3M | ||
| Q1 25 | $223.7M | $-166.5M | ||
| Q4 24 | $182.4M | $-79.3M | ||
| Q3 24 | $182.9M | $-67.0M | ||
| Q2 24 | $169.2M | $-77.0M |
| Q1 26 | — | — | ||
| Q4 25 | $230.2M | $-100.8M | ||
| Q3 25 | $215.1M | $-92.7M | ||
| Q2 25 | $183.0M | $-110.7M | ||
| Q1 25 | $223.5M | $-167.8M | ||
| Q4 24 | $181.9M | $-79.5M | ||
| Q3 24 | $182.5M | $-68.6M | ||
| Q2 24 | $169.0M | $-79.0M |
| Q1 26 | — | — | ||
| Q4 25 | 77.1% | -48.6% | ||
| Q3 25 | 70.6% | -58.0% | ||
| Q2 25 | 60.1% | -66.5% | ||
| Q1 25 | 73.0% | -120.5% | ||
| Q4 24 | 60.3% | -48.3% | ||
| Q3 24 | 59.5% | -49.2% | ||
| Q2 24 | 55.3% | -53.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 0.5% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.2% | 0.1% | ||
| Q3 24 | 0.1% | 1.2% | ||
| Q2 24 | 0.1% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.13× | — | ||
| Q2 25 | 0.95× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | 0.99× | — | ||
| Q3 24 | 0.91× | — | ||
| Q2 24 | 0.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MTG
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
